Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2014-08-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1073/pnas.1412608111PMID 25092309PMCID PMC4143020
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miRBase: annotating high confidence microRNAs using deep sequencing data

  2013cited by this paper
• Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer

  2013cited by this paper
• Use of acetylcysteine for non-acetaminophen-induced acute liver failure.

  2013cited by this paper
• 265 PLASMA MICRORNAS AS BIOMARKERS FOR PLATELET INHIBITION

  2013cited by this paper
• Circulating Cell and Plasma microRNA Profiles Differ between Non-ST-Segment and ST-Segment-Elevation Myocardial Infarction

  2013cited by this paper
• Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity

  2012cited by this paper
• Comparing the MicroRNA Spectrum between Serum and Plasma

  2012cited by this paper
• Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

  2012cited by this paper
• miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer

  2012cited by this paper
• Plasma microRNA profiles distinguish lethal injury in acetaminophen toxicity: a research study.

  2012cited by this paper
• Spotlight Issue: MicroRNAs in the Microcirculation—From Cellular Mechanisms to Clinical Markers

  2012cited by this paper
• Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

  2011cited by this paper
• MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins

  2011cited by this paper
• Emergency department visits for overdoses of acetaminophen-containing products.

  2011influential reference
• Circulating microRNAs as potential markers of human drug‐induced liver injury

  2011cited by this paper
• When do the aminotransferases rise after acute acetaminophen overdose?

  2010cited by this paper
• Review article: the current management of acute liver failure

  2010cited by this paper
• Circulating microRNAs, potential biomarkers for drug-induced liver injury

  2009cited by this paper
• Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose.

  2009cited by this paper
• Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

  2009cited by this paper
• 2008 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual Report

  2009cited by this paper
• Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose.

  2009cited by this paper
• Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

  2007cited by this paper
• A mammalian microRNA expression atlas based on small RNA library sequencing.

  2007cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2005cited by this paper
• ROCR: visualizing classifier performance in R

  2005cited by this paper
• Data clustering using evidence accumulation

  2002cited by this paper
• Minireview Micrornas: Tiny Regulators with Great Potential

  2001cited by this paper
• The Human and Economic Cost of Paracetamol (Acetaminophen) Overdose

  1995cited by this paper
• A k-means clustering algorithm

  1979cited by this paper
• Algorithm AS136: A k-means clustering algorithm.

  1979cited by this paper

• Extrahepatic and Circulating miR-122: Diagnostic Implications and Future Directions.

  2025cites this paper
• Pre-analytical considerations for microRNA quantification in childhood leukemia research

  2025cites this paper
• miRNAs in patients with alcoholic liver disease: a systematic review and meta-analysis

  2024cites this paper
• The potential role of extracellular vesicles as hepatic diagnostic and therapeutic tools: Can the dream come true?

  2024cites this paper
• Hepatocyte miR-21-5p-deficiency Alleviates APAP-Induced Liver injury by inducing PPARγ and Autophagy.

  2024cites this paper
• Molecular Pathways Governing the Termination of Liver Regeneration

  2024cites this paper
• Advances in drug-induced liver injury research: in vitro models, mechanisms, omics and gene modulation techniques

  2024cites this paper
• The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver.

  2023cites this paper
• Loss of microRNA-21 protects against acetaminophen-induced hepatotoxicity in mice

  2023cites this paper
• Expression Analysis of Exosomal MicroRNAs in Chlorpromazine Treated Human Hepatic Spheroids: A Promising Tool for Novel Drug-Induced Liver Injury Biomarker Discovery

  2023cites this paper
• miRNA-ome plasma analysis unveils changes in blood–brain barrier integrity associated with acute liver failure in rats

  2023cites this paper
• The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review.

  2023cites this paper
• Analysis of serum microRNA‐122 in a randomized controlled trial of N‐acetylcysteine for treatment of antituberculosis drug‐induced liver injury

  2023cites this paper
• Title Page Central Mechanisms of Acetaminophen Hepatotoxicity: Mitochondrial Dysfunction by Protein Adducts and Oxidant Stress

  2023cites this paper
• Modulation of miR-146b Expression during Aging and the Impact of Physical Activity on Its Expression and Chondrogenic Progenitors

  2023cites this paper
• Central Mechanisms of Acetaminophen Hepatotoxicity: Mitochondrial Dysfunction by Protein Adducts and Oxidant Stress

  2023cites this paper
• MicroRNAs: Small molecules with big impacts in liver injury

  2022influential citation
• Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study

  2022cites this paper
• Chemokines in Primary Liver Cancer

  2022cites this paper
• Special Section on Drug Metabolism in Liver Injury and Repair — Minireview Novel Clinical Biomarkers for Drug-Induced Liver Injury S

  2022influential citation
• MicroRNAs in Various Body Fluids and its importance in Forensic Medicine.

  2022cites this paper
• Nucleic acid biomarkers to assess graft injury after liver transplantation

  2022cites this paper
• Methodological considerations for measuring biofluid-based microRNA biomarkers

  2021cites this paper
• Advances in the diagnosis of drug-induced liver injury

  2021cites this paper
• Insight into microRNAs-Mediated Communication between Liver and Brain: A Possible Approach for Understanding Acute Liver Failure?

  2021cites this paper
• Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study

  2021cites this paper
• Unbiased and UMI-informed sequencing of cell-free miRNAs at single-nucleotide resolution

  2021cites this paper
• Models of Drug Induced Liver Injury (DILI)-Current Issues and Future Perspectives

  2021cites this paper
• Novel Clinical Biomarkers for Drug-Induced Liver Injury

  2021cites this paper
• Role of Non-coding RNA in Acetaminophen-induced Liver Injury.

  2021cites this paper
• Atherosclerosis Pathways are Activated in Pericoronary Adipose Tissue of Patients with Coronary Artery Disease

  2021cites this paper
• Research status and progress of drug induced liver injury

  2021cites this paper
• cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?

  2020cites this paper
• Amplification-free profiling of microRNA-122 biomarker in DILI patient serums, using the luminex MAGPIX system.

  2020cites this paper
• MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury

  2020cites this paper
• Granzyme B and miR-378a Interaction in Acetaminophen Toxicity in Children

  2020cites this paper
• Microbiota-governed microRNA-204 impairs endothelial function and blood pressure decline during inactivity in db/db mice

  2020cites this paper
• Zebrafish as an integrative vertebrate model to identify miRNA mechanisms regulating toxicity

  2020cites this paper
• Advances in biomarker development in acetaminophen toxicity.

  2020cites this paper
• miRNA-338-3p/CAMK IIα signaling pathway prevents acetaminophen-induced acute liver inflammation in vivo.

  2020cites this paper
• Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors

  2020cites this paper
• Storage of saliva and blood specimen in different temperature

  2020cites this paper
• SIX1/EYA1 are novel liver damage biomarkers in chronic hepatitis B and other liver diseases

  2020cites this paper
• Multiple microRNAs regulate tacrolimus metabolism through CYP3A5.

  2020cites this paper
• Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity

  2020cites this paper
• MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases

  2020cites this paper
• MicroRNA‐125b‐5p Regulates Hepatocyte Proliferation During the Termination Phase of Liver Regeneration

  2020cites this paper
• Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides

  2020cites this paper
• Polycyclic aromatic hydrocarbons can trigger hepatocyte release of extracellular vesicles by various mechanisms of action depending on their affinity for the aryl hydrocarbon receptor.

  2019cites this paper
• Biomarkers of drug-induced liver injury.

  2019cites this paper
• Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure.

  2019cites this paper
• A scrutiny of circulating microRNA biomarkers for drug-induced tubular and glomerular injury in rats.

  2019cites this paper
• In Vivo Real-Time Imaging of Extracellular Vesicles in Liver Regeneration via Aggregation-Induced Emission Luminogens.

  2019cites this paper
• Predicting Postoperative Liver Dysfunction Based on Blood‐Derived MicroRNA Signatures

  2019cites this paper
• Acetaminophen Hepatotoxicity

  2019cites this paper
• Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease

  2019cites this paper
• Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.

  2019cites this paper
• MicroRNA Expression as an Indicator of Tissue Toxicity and a Biomarker in Disease and Drug-Induced Toxicological Evaluation

  2019cites this paper
• New strategy for determination of anti-viral drugs based on highly conductive layered composite of MnO2/graphene/ionic liquid crystal/carbon nanotubes

  2019cites this paper
• The Relationship Between Circulating Acetaminophen-Protein Adduct Concentrations and Alanine Aminotransferase Activities in Patients With and Without Acetaminophen Overdose and Toxicity

  2019cites this paper
• A comparison of RNA extraction and sequencing protocols for detection of small RNAs in plasma

  2019cites this paper
• Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity

  2019cites this paper
• Variance component analysis of circulating miR-122 in serum from healthy human volunteers

  2019cites this paper
• Non-coding RNAs and drug-induced liver injury

  2019cites this paper
• Early biomarkers for severe drug hypersensitivity reactions.

  2019cites this paper
• Circulating microRNA Profiles in Acetaminophen Toxicity

  2019cites this paper
• miRNAs Signatures In Patients With Acute Liver Injury: Clinical Concerns and Correlations.

  2019cites this paper
• Novel biomarkers for potential risk stratification of drug induced liver injury (DILI)

  2019cites this paper
• Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection

  2019cites this paper
• Integrative Toxicogenomics: Analytical Strategies to Amalgamate Exposure Effects With Genomic Sciences

  2019cites this paper
• Comparing Hepatoprotective Effects of Aqueous Extract of Cassia Fistula ( Amaltas ) Leaves and Silymarin

  2018cites this paper
• Serum biomarkers of drug‐induced liver injury: Current status and future directions

  2018cites this paper
• Human plasma and serum extracellular small RNA reference profiles and their clinical utility

  2018cites this paper
• Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives

  2018cites this paper
• Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives

  2018cites this paper
• The diagnostic role of miR-122 in drug-induced liver injury

  2018cites this paper
• Optimizing drug discovery by Investigative Toxicology: Current and future trends.

  2018cites this paper
• University of Birmingham Transcriptional responses reveal similarities between preclinical rat liver testing systems

  2018cites this paper
• The association between plasma miR-122-5p release pattern at admission and all-cause mortality or shock after out-of-hospital cardiac arrest

  2018cites this paper
• High-throughput chemical screening to discover new modulators of microRNA expression in living cells by using graphene-based biosensor

  2018cites this paper
• Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation

  2018cites this paper
• University of Birmingham Transcriptional responses reveal similarities between preclinical rat liver testing systems

  2018cites this paper
• Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats

  2018cites this paper
• Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human

  2018cites this paper
• Comparison of microRNA expressions for the identification of chemical hazards in in vivo and in vitro hepatic injury models

  2018cites this paper
• Circulating MicroRNAs as Novel Biomarkers of Drug-Induced Liver Injury in Humans

  2018cites this paper
• The plasma miR-122 basal levels respond to circulating catecholamines in rats

  2018cites this paper
• The Role of microRNAs in the Gut-Liver Axis

  2018cites this paper
• Detection of circulating extracellular mRNAs by modified small RNA-sequencing analysis

  2018cites this paper
• University of Birmingham Transcriptional responses reveal similarities between preclinical rat liver testing systems

  2018cites this paper
• Transcriptional Responses Reveal Similarities Between Preclinical Rat Liver Testing Systems

  2018cites this paper
• MicroRNAs as biomarkers for clinical studies

  2018cites this paper
• Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans

  2018cites this paper
• Extracellular vesicles as potential biomarkers for alcohol‐ and drug‐induced liver injury and their therapeutic applications

  2018cites this paper
• miR-3646 promotes vascular inflammation and augments vascular smooth muscle cell proliferation and migration in progression of coronary artery disease by directly targeting RHOH.

  2018cites this paper
• Nonacetaminophen Drug-Induced Acute Liver Failure.

  2018cites this paper
• Comprehensive Evaluation of a Donated After Circulatory Death (DCD) Donor Liver Model in Minipigs

  2018cites this paper
• MiR-122 and other microRNAs as potential circulating biomarkers of drug-induced liver injury

  2018cites this paper
• Mechanisms of Acetaminophen Hepatotoxicity: Cell Death Signaling Mechanisms in Hepatocytes

  2018cites this paper
• MicroRNA regulation of CYP 1A2, CYP3A4 and CYP2E1 expression in acetaminophen toxicity

  2017cites this paper